Wells Fargo’s Biora Therapeutics, Inc. Common Stock BIOR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-400
| Closed | -$2.01K | – | 6728 |
|
|
2024
Q3 | $2.01K | Sell |
400
-9
| -2% | -$45 | ﹤0.01% | 5647 |
|
|
2024
Q2 | $2.7K | Sell |
409
-770
| -65% | -$5.08K | ﹤0.01% | 5590 |
|
|
2024
Q1 | $13K | Buy |
1,179
+363
| +44% | +$3.99K | ﹤0.01% | 5304 |
|
|
2023
Q4 | $11K | Buy |
816
+1
| +0.1% | +$13 | ﹤0.01% | 5376 |
|
|
2023
Q3 | $17.7K | Buy |
815
+421
| +107% | +$9.13K | ﹤0.01% | 5281 |
|
|
2023
Q2 | $15.2K | Sell |
394
-2
| -0.5% | -$77 | ﹤0.01% | 5512 |
|
|
2023
Q1 | $11K | Buy |
396
+242
| +157% | +$6.7K | ﹤0.01% | 5518 |
|
|
2022
Q4 | $5.07K | Sell |
154
-6
| -4% | -$198 | ﹤0.01% | 5443 |
|
|
2022
Q3 | $19K | Hold |
160
| – | – | ﹤0.01% | 5114 |
|
|
2022
Q2 | $28K | Sell |
160
-19
| -11% | -$3.33K | ﹤0.01% | 5008 |
|
|
2022
Q1 | $52K | Sell |
179
-76
| -30% | -$22.1K | ﹤0.01% | 5311 |
|
|
2021
Q4 | $134K | Buy |
255
+104
| +69% | +$54.7K | ﹤0.01% | 5102 |
|
|
2021
Q3 | $57K | Buy |
151
+21
| +16% | +$7.93K | ﹤0.01% | 5276 |
|
|
2021
Q2 | $116K | Buy |
130
+10
| +8% | +$8.92K | ﹤0.01% | 4941 |
|
|
2021
Q1 | $143K | Sell |
120
-321
| -73% | -$383K | ﹤0.01% | 4996 |
|
|
2020
Q4 | $586K | Sell |
441
-1,185
| -73% | -$1.57M | ﹤0.01% | 4335 |
|
|
2020
Q3 | $3.67M | Sell |
1,626
-105
| -6% | -$237K | ﹤0.01% | 2760 |
|
|
2020
Q2 | $3.9M | Buy |
+1,731
| New | +$3.9M | ﹤0.01% | 2682 |
|